TNF-α Serum Level Elevations in Chronic Hepatitis C Patients with Diabetes Mellitus

Hahn Y.S. 2003. Subversion of immune responses by hepatitis C virus: Immunomodulatory strategies beyond evasion? Curr. Opin. Immunol. 15:443.

Knobler H. Zhornicky T. Sandler A. Haran N. Ashur Y. Schattner A. , 2003. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am. J. Gastroenterol. 98:2751.

Shintani Y. Fujie H. Miyoshi H. Tsutsumi T. Tsukamoto K. Kimura S. Moriya K. Koike K. 2004. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterol. 126:840.

Nelson D.R. Lim H.L. Marousis C.G. Fang J.W. Davis G.L. Shen L. Urdea M.S. Kolberg J.A. Lau J.Y. , 1997. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig. Dis. Sci. 42:2487.

Uysal K.T. Wiesbrock S.M. Marino M.W. Hotamisligil G.S. , 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 9:610.

Perrella A. Tarantino G. Borgia G. Conca P. Sorrentino P. Ragucci P. Vecchione R. Perrella O. , 2003. Cytokine network during NASH and possible treatment selection. Hepatol. 38:530

Lonardo A. Adinolfi L.E. Loria P. Carulli N. Ruggiero G. Day C.P. , 2004. Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease. Gastroenterol. 126:586.